For research use only. Not for therapeutic Use.
LX7101 is a small-molecule inhibitor primarily studied for its potential therapeutic effects in treating ocular diseases, particularly glaucoma. It works by inhibiting specific kinases, including LIM kinase and ROCK (Rho-associated coiled-coil kinase), which play roles in regulating intraocular pressure and optic nerve protection. LX7101 has demonstrated promise in preclinical models for lowering intraocular pressure and protecting retinal ganglion cells. Its ability to target multiple pathways makes it a valuable candidate in the development of new treatments for glaucoma and related conditions.
| Catalog Number | I000697 |
| CAS Number | 1192189-69-7 |
| Synonyms | [3-[[4-(aminomethyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carbonyl]amino]phenyl] N,N-dimethylcarbamate |
| Molecular Formula | C23H29N7O3 |
| Purity | ≥95% |
| InChI | InChI=1S/C23H29N7O3/c1-15-12-25-19-18(15)20(27-14-26-19)30-9-7-23(13-24,8-10-30)21(31)28-16-5-4-6-17(11-16)33-22(32)29(2)3/h4-6,11-12,14H,7-10,13,24H2,1-3H3,(H,28,31)(H,25,26,27) |
| InChIKey | PWPNYABQEOGNNC-UHFFFAOYSA-N |
| SMILES | CC1=CNC2=C1C(=NC=N2)N3CCC(CC3)(CN)C(=O)NC4=CC(=CC=C4)OC(=O)N(C)C |
